Across TCGA patient cohorts, C9orf163 mutation is significantly associated with the RNA expression of many other genes, with 83 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible C9orf163-associated genes across cancer lineages are RN7SL162P, RNU6-192P, and LINC02333. Each is linked with C9orf163 in more than 1 cancer types. Because this analysis shows association rather than direction, both C9orf163-to-partner and partner-to-C9orf163 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (C9orf163→partner) and Y-score (partner→C9orf163) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	RN7SL162P →	+0.407	+3.191	<.001	.002	3	2
UCEC	RNU6-192P →	+0.409	+4.115	<.001	.001	3	2
UCEC	LINC02333 →	+0.094	+3.246	<.001	.008	3	1
UCEC	MYHAS →	+0.135	+2.890	<.001	.008	3	1
UCEC	MIR6133 →	+0.568	+3.246	<.001	.008	3	1
UCEC	MIR6509 →	+0.782	+3.014	<.001	.004	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 83 associations by consensus.

Exploration

C9orf163 survival (RNA) · tumor vs normal (RNA) · all C9orf163 data types